Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

65.65
+0.14000.21%
Volume:708.53K
Turnover:46.45M
Market Cap:12.69B
PE:173.23
High:66.00
Open:65.96
Low:65.29
Close:65.51
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:0.44
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.01
PE(LYR):36.47

Loading ...

Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Major Issues Report

8-K - Current report
May 01, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

Major Issues Report

8-K - Current report
Apr 22, 2020

Major Issues Report

8-K - Current report
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, item 5.02
Nov 04, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Oct 29, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 23, 2019

Major Issues Report

Current report, items 2.02 and 9.01